Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-02-22 @ 10:54 PM
Study NCT ID:
NCT05245994
Status:
UNKNOWN
Last Update Posted:
2022-02-18
First Post:
2022-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
Sponsor:
Li Zhang, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ESR-20-20659
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None